Expected earnings - 4D Molecular Therapeutics Inc.
Source: US Earnings Reports
4D Molecular Therapeutics Inc. (FDMT) is expected to report $-0.88 for Q2 2025
4D Molecular Therapeutics Inc.
NASDAQ: FDMT
FDMT Trading
0.78% G/L:
$9.66 Last:
196,518 Volume:
$9.75 Open:
FDMT Latest News
March 18, 2026 04:05:00 pm
4DMT Reports Full Year 2025 Financial Results, Operational Highlights and Expected Upcoming MilestonesFDMT Stock Data
$519,643,507
47,993,463
N/A
51
N/A
Biotechnology & Life Sciences
Healthcare
US
Emeryville
